Justin Chakma

Affiliations

  • Chief Business Officer at Ars Pharmaceuticals Inc. (SPRY), 2025-01-03
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SPRY $12.06 27,272 $328,968.50 136,380 2024-12-13 Filing
SPRY $12.27 117,333 $1,439,124.44 136,380 2024-12-12 Filing
SPRY $13.15 50,000 $657,625.00 136,380 2024-12-10 Filing
SPRY $14.23 50,000 $711,615.00 136,380 2024-12-06 Filing
SPRY $14.13 49,640 $701,641.54 136,380 2024-12-05 Filing